When was Jazz Pharmaceuticals founded?

Jazz Pharmaceuticals was founded in 2003 and raised its 1st funding round within a year of its incorporation.

Where is Jazz Pharmaceuticals located?

Jazz Pharmaceuticals is headquartered in Dublin, Ireland.

Who is the current CEO of Jazz Pharmaceuticals?

Bruce C Cozadd and Roxy Rox s of Jazz Pharmaceuticals. Bruce C Cozadd has also founded 1 company.

How many employees does Jazz Pharmaceuticals have?

As of Sep 30, 2026, the latest employee count at Jazz Pharmaceuticals is 3671.

Is Jazz Pharmaceuticals a funded company?

Jazz Pharmaceuticals is a funded company, having raised a total of $265M across 3 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Apr 2003.

When was the latest funding round of Jazz Pharmaceuticals?

Jazz Pharmaceuticals' latest funding was a $***** Post IPO round on Jul 07, 2009, with participation from 1 investor.

What is the annual revenue of Jazz Pharmaceuticals?

Annual revenue of Jazz Pharmaceuticals is between $500M and $1B as on Dec 31, 2020

Where does Jazz Pharmaceuticals rank among its competitors?

Jazz Pharmaceuticals ranks 1st amongst 3752 active competitors, of which 1262 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Sana Biotechnology, which secured $25M in Aug, 2026.

Who are the top competitors of Jazz Pharmaceuticals?

Jazz Pharmaceuticals' top competitors include BeiGene, Biogen and PTC Therapeutics. Among them, Sana Biotechnology secured the most recent funding round in August, 2026.

Jazz Pharmaceuticals - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of novel biopharmaceutical medicines for unmet medical needs. It focuses on developing and delivering life-changing medications to patients with limited or no treatment options. The company's pipeline includes various therapeutic areas, and it supports its medicines with robust clinical trial programs and patient support resources. Research efforts prioritize patient needs, driving advancements in understanding and treating specific conditions. The company also engages in corporate giving and sustainability initiatives.

Website: www.jazzpharma.com/
Social
Email ID: *****@jazzpharma.com
Phone Number: +353 **********

Key Metrics

Founded Year

2003

Location

Dublin, Ireland

Stage

Public

Total Funding

$265M in 3 rounds

Latest Funding Round

Post IPO, Jul 07, 2009, $*****

Investors

KKR & 15 more

Ranked

1^st among 3752 active competitors

Annual Revenue

$500M - $1B as on Dec 31, 2020

Employee Count

3,671 as on Sep 30, 2026

Investment & Acquisitions

Actio Biosciences & 8 more

Similar Companies

Biogen & 3518 more

Exit Details

Public

View Jazz Pharmaceuticals' full profile

Jazz Pharmaceuticals is associated with 4 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY CIN: 399192 , Ireland, Active	Mar 15, 2005	$1B+ (As on Dec 31, 2024)	-	-
Jazz Pharmaceuticals Denmark ApS CIN: 39791447 , Denmark, Active	Aug 16, 2018	-	12 (As on Mar 31, 2024)
GW PHARMACEUTICALS PLC CIN: 1351288 , United States, Active		$500M - $1B (As on Dec 31, 2020)	-	-
JAZZ PHARMACEUTICALS PLC CIN: 1232524 , United States, Active		$1B+ (As on Dec 31, 2025)	2800 (As on Dec 31, 2024)	-

Jazz Pharmaceuticals got listed on Jun 01, 2007.

Click here to take a look at Jazz Pharmaceuticals's IPO in detail

Jazz Pharmaceuticals has raised a total funding of $265M over 3 rounds. Its first funding round was on Apr 2003. Its latest funding round was a Post IPO round on Jul 07, 2009 for $*****. 1 investor participated in its latest round. Jazz Pharmaceuticals has 16 institutional investors.

Here is the list of recent funding rounds of Jazz Pharmaceuticals:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 07, 2009	8315381	Post IPO	8282203	9931115	5140773	6716993
Mar 24, 2004	8148842	Series B	1092761	7238642	6019295	Adams Street Partners & 9 more
Apr 2003	4235499	Series A	7437818	4403757	Prospect Venture Partners & 1 more	9648119

Access funding benchmarks and valuations. Sign up today!

View details of Jazz Pharmaceuticals's funding rounds and investors

The founders of Jazz Pharmaceuticals is Bruce C Cozadd. Bruce C Cozadd, Roxy Rox and Renee Gala are the CEOs of Jazz Pharmaceuticals.

Here are the details of Jazz Pharmaceuticals' key team members:

Bruce C Cozadd: Co-Founder & CEO of Jazz Pharmaceuticals.
Contact Info: 1 email address
Roxy Rox: CEO of Jazz Pharmaceuticals.

View details of Jazz Pharmaceuticals's Founder profiles and Board Members

Jazz Pharmaceuticals' employee count trend

Jazz Pharmaceuticals has 3,671 employees as of Sep 26. Here is Jazz Pharmaceuticals's employee count trend over the years:

Employee count trend for Jazz Pharmaceuticals

Uncover Jazz Pharmaceuticals' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Jazz Pharmaceuticals include BeiGene, Biogen and PTC Therapeutics. Here is the list of Top 10 competitors of Jazz Pharmaceuticals, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Adams Street Partners, Thoma Bravo & 14 others	82/100
2nd	BeiGene 2010, Cambridge (United States), Public	Developer of targeted and immune-oncology drugs against cancer	$172M	Hillhouse, T. Rowe Price & 13 others	81/100
3rd	Biogen 1978, Cambridge (United States), Public	Developer of therapies for neurodegenerative and immunology disorders	$80M	Berkshire Hathaway, Digital Pharma Lab & 11 others	78/100
4th	PTC Therapeutics 1998, South Plainfield (United States), Public	Developer of small molecule drugs for the treatment of rare diseases	$248M	HBM Healthcare Investments, Credit Suisse First Boston ... & 28 others	77/100
5th	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, PSP Investments & 18 others	74/100
6th	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	73/100
7th	Senti Bio 2016, San Francisco (United States), Public	Developer of cell and gene therapies for patients living with incurable diseases	$158M	Celadon Partners, Leaps by Bayer & 30 others	72/100
8th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
9th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
10th	Moderna 2010, Cambridge (United States), Public	Developer of mRNA-based therapeutics for a wide range of diseases	$2.78B	Merck, AstraZeneca & 32 others	72/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Jazz Pharmaceuticals's competitors? Click here to see the top ones

Jazz Pharmaceuticals has made 4 investments in companies including Onera and Onera. Jazz Pharmaceuticals has also acquired 5 companies including Actio Biosciences and Chimerix.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Aug 10, 2026	Acquisition	Actio Biosciences	2021	San Diego (United States)
Mar 05, 2025	Acquisition	Chimerix	2002	Durham (United Kingdom)
Jul 29, 2021	Investments	Onera	2018	Palo Alto (United States)

Want to know more about where corporates are investing? Sign up today!

See all investments and acquisitions by Jazz Pharmaceuticals

Here is the latest report on Jazz Pharmaceuticals's sector:

Free

Oncology - Sector Report

Edition: August, 2026 (74 Pages)

View all reports related to Jazz Pharmaceuticals

Media has covered Jazz Pharmaceuticals for a total of 56 events in the last 1 year, 30 of them have been about company updates and 4 about partnerships.